Skip to main content
Equibles

Paul Scherer, M.D.

Board Member

Prelude Therapeutics Inc (PRLD)

Equibles does not estimate personal net worth.

Get an email with a short summary when Prelude Therapeutics Inc publishes a filing, an earnings call transcript or a press release.

Get PRLD alerts

About Paul Scherer, M.D.

Paul Scherer, M.D. is recorded as Board Member at Prelude Therapeutics Inc (PRLD) since June 12, 2025. Prelude Therapeutics Inc reported in an 8-K filed June 13, 2025 that Paul Scherer, M.D. was appointed Class III director, effective June 12, 2025. Prelude Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prelude Therapeutics Inc includes Krishna Vaddi (CEO and Board Member), Bryant D. Lim (CFO), Julian C. Baker (Board Member) and 2 others.

“On June 11, 2025, upon the recommendation of the Nominating and Corporate Governance Committee (the "Governance Committee") of the Board of Directors (the "Board") of Prelude Therapeutics Incorporated (the "Company"), the Board appointed Paul Scherer, M.D., as a Class III director and as a member of the Compensation committee and the Governance Committee of the Board, effective as of the adjournment of the 2025 Annual Meeting of Stockholders (the "Annual Meeting") on June 12, 2025 (the "Effective Date").”
Prelude Therapeutics Inc Form 8-K, filed June 13, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Prelude Therapeutics Inc

Recent activity